Onward Medical N.V. (ONWRF)

Market Cap	230.69M
Revenue (ttm)	1.80M
Net Income (ttm)	-36.99M
Shares Out	n/a
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	1,335
Open	4.670
Previous Close	4.600
Day's Range	4.670 - 4.670
52-Week Range	4.410 - 7.040
Beta	0.86
RSI	43.15
Earnings Date	Jun 17, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Employees: 103
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONWRF

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.

Financial numbers in EUR